Rise in Cases of Kids Infected With Virus Linked to Paralyzing Illness
WEDNESDAY, Sept. 28, 2022 (HealthDay News) – Cases of a virus that strikes children and teens and can trigger paralysis in rare cases have been increasing in the United States and could continue to do so this fall, health officials warned Tuesday. Inc…
Learn MoreTwo Cases Show COVID Virus Mutating Around Standard Treatment Remdesivir
WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports.After lengthy COVID infections, two kidney transplant …
Learn MoreEn EE. UU., 4.4 millones de personas se han puesto los refuerzos actualizados contra la COVID
VIERNES, 23 de septiembre de 2022 (HealthDay News) — Al menos 4.4 millones de estadounidenses han recibido la vacuna de refuerzo actualizada contra la COVID-19.Los Centros para el Control y la Prevención de Enfermedades (CDC) de EE. UU. publicaron la…
Learn More4.4 Million Americans Have Gotten Updated COVID Boosters
FRIDAY, Sept. 23, 2022 (HealthDay News) — At least 4.4 million Americans have received the updated COVID-19 booster shot.The U.S. Centers for Disease Control and Prevention posted the count Thursday as public health experts decried President Joe Bide…
Learn MoreNeuropsychiatric Manifestations Seen in Monkeypox Patients
THURSDAY, Sept. 22, 2022 (HealthDay News) — Neuropsychiatric presentations, including seizure, confusion, and encephalitis, have been reported among patients with monkeypox infection, according to a review published online Sept. 8 in eClinicalMedicin…
Learn MoreRisk of Monkeypox Transmission Low in Health Care Settings
TUESDAY, Sept. 20, 2022 (HealthDay News) — The risk of transmission of monkeypox is low in health care settings, according to research published in the Sept. 16 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and…
Learn More¿Qué medicamentos funcionan mejor contra la COVID? La OMS actualiza las directrices de tratamiento
VIERNES, 16 de septiembre de 2022 (HealthDay News) — En una directriz que se actualizó el jueves, la Organización Mundial de la Salud (OMS) desaconseja ahora utilizar los medicamentos de anticuerpos sotrovimab y casirivimab-imdevimab en los pacientes…
Learn MoreFDA Warns Against Overuse of TPOXX Monkeypox Drug
FRIDAY, Sept. 16, 2022 (HealthDay News) — U.S. health officials are advising doctors not to overuse the only antiviral for monkeypox because there is a risk for the virus mutating and rendering the drug useless.TPOXX (tecovirimat) works by targeting …
Learn MoreBajan los casos de viruela del simio en EE. UU., pero a las autoridades les preocupa llegar a las minorías
JUEVES, 15 de septiembre de 2022 (HealthDay News) — Los casos de viruela del simio siguen reduciéndose en Estados Unidos, pero ahora a las autoridades de salud pública les preocupa que el virus se esté abriendo camino en las comunidades de color.Los…
Learn MoreFDA Warns Against Overuse of TPOXX Monkeypox Drug
FRIDAY, Sept. 16, 2022 (HealthDay News) — U.S. health officials are advising doctors not to overuse the only antiviral for monkeypox because there is a risk of the virus mutating and rendering the drug useless.TPOXX (tecovirimat) works by targeting j…
Learn More